Objective: The timing of menopause is associated with multiple chronic diseases. Tools that predict this milestone have relevance for clinical and research purposes. Among infertile women, a positive relationship exists between antral follicle count (AFC) and response to controlled ovarian hyperstimulation, a marker of ovarian reserve. However, an age-independent relationship between AFC and menopause has not been demonstrated. Thus, our objective was to evaluate the relationship between AFC measured in women aged 34 to 49 years and incident natural menopause during 7 years of follow-up.
M enopause is an inevitable life event for most women (and all women who live long enough) and is thought to represent the complete cessation of ovarian oocyte production. The timing of menopause is associated with multiple chronic diseases, such as coronary heart disease, stroke, breast cancer, and osteoporosis. 1<6 Thus, tools that predict this milestone have potential relevance to the assessment of chronic disease risk for epidemiologic and clinical purposes.
Antral follicle count (AFC) is a tool that accurately predicts the ovary's ability to produce oocytes when stimulated by gonadotropins, 7 but AFC's ability to predict menopause is relatively unstudied because of the length of follow-up needed to assess this outcome. Broer et al 8 followed 185 Dutch women for 11 years, with 48 women experiencing menopause. They did not find an independent association between baseline AFC and future menopause after controlling for age. Our aim was to examine AFC's association with incident menopause in a larger sample of black and white premenopausal women recruited from the community.
METHODS

Study population
Data were obtained from the Coronary Artery Risk Development in Young Adults (CARDIA) Study (a longitudinal epidemiologic investigation of the evolution of cardiovascular risk among young adults 9, 10 ) and the ancillary CARDIA Women's Study (CWS). For CARDIA, participants aged 18 to 30 years were recruited from the populations of Birmingham, Chicago, and Minneapolis and through membership in a large healthcare plan (Oakland, CA). In 1985-1986, baseline examinations were performed on 5,115 (51% of eligible persons contacted) individuals, including 2,788 women. The population was balanced according to age, sex, education, and race at each CARDIA site. A description of the methodology for recruiting participants and for performing data collection is detailed elsewhere. 9, 10 The CWS was an ancillary study to CARDIA designed to examine the associations of androgens, polycystic ovaries, and the clinical features of polycystic ovarian syndrome with subclinical atherosclerosis. Women eligible for the CWS must have attended the 2000-2001 CARDIA examination, must have at least one ovary, and must not be pregnant. The CWS examination occurred in 2002-2003, and examination components are detailed elsewhere. 11<13
Sample selection
A total of 1,163 women participated in the CWS. The initial CWS transvaginal ultrasound (TVUS) protocol did not include AFC. In 2003, however, the protocol was changed to include AFC. This change was made secondary to the publication of the Rotterdam criteria for defining polycystic ovarian syndrome, which included follicle count assessment. Thus, of the 1,163 CWS participants, 705 women underwent a TVUS protocol that included AFC. With regard to the demographic and clinical characteristics listed in Table 1 , compared with the women enrolled in the CWS who underwent a TVUS protocol that included AFC (n = 705), the 458 women who did not undergo the TVUS protocol and were not included were younger (41.7 vs 42.4; P = 0.002), more often black (58% vs 50%; P = 0.005), and less often from Minneapolis, MN (0% vs 34%; P G 0.001).
For the current analyses, participants were included only if they had undergone a TVUS protocol that included AFC measurement (n = 705; Fig. 1 ). Participants were excluded if they were missing one ovary, both ovaries, or a uterus on TVUS (n = 130). Participants were excluded if they were missing covariates (n = 18) After these exclusions, 456 women remained in the final sample ( Fig. 1) .
Compared with the final sample (n = 456), excluded women with measured follicle-stimulating hormone (FSH) levels (n = 243 of 249 excluded) or measured body mass in-dex (BMI; n = 248 of 249 excluded) had higher FSH levels (18.1 mIU/mL in excluded women vs 11.3 mIU/mL in included women; P G 0.001) and BMI (31.2 kg/m 2 in excluded women vs 29.7 kg/m 2 in included women; P = 0.01).
Variables
Transvaginal ultrasound
TVUS was performed by American Registry for Diagnostic Medical SonographyYcertified sonographers and targeted to the follicular menstrual cycle phase in regularly cycling women. Thirteen sonographers (two to five sonographers per CARDIA field center site) performed TVUS on participants in the current analyses. A 5-to 7.5-MHz vaginal probe was used to search for each ovary. If no ovary was found after 2 minutes, iliac vessels were photographed. When an ovary was found, antral follicles (follicles measuring 2-10 mm) were counted. AFC comprised the total number of follicles on both ovaries.
The CWS included a quality assurance (QA) protocol for ultrasonography. For our analyses, data from repeated TVUS by a QA sonographer were available for a subset of 28 participants. For an AFC of 4 or less versus an AFC higher than 4, the interrater reliability between the QA ultrasound and the original ultrasound was high (J = 0.85).
Follicle-stimulating hormone
Blood samples were drawn on the day of TVUS. Within 1 hour of blood draw, samples were processed into aliquots and frozen. University of Alabama Birmingham, the intra-assay coefficients of variation ranged from 3.8% to 5.4%, and the interassay coefficients of variation ranged from 3.9% to 4.2% .
Menopause
The primary outcome was incident natural menopause assessed by self-report. Participants completed a self-administered questionnaire (2005) (2006) 
Other gynecologic characteristics
In the CWS, participants who affirmed that they had experienced menses in the previous 12 months and denied that they were always pregnant, breast-feeding, or using hormonal contraception during the previous 12 months were also asked the following question: BIn the past 12 months, have your periods: (1) become farther apart, (2) become closer together, (3) occurred at more variable intervals, (4) stayed the same, or (5) stopped completely, or (6) (2000) (2001) were measured according to standardized protocols. 15 BMI was computed in kilograms per meter squared.
Statistical methods
Goodness-of-fit analyses were used to determine the optimal dichotomous cutpoint for AFC (range, 0-25) and FSH level (range, 1-60 mIU/mL). Goodness of fit, as reflected by c-statistics, was maximized for the prediction of incident menopause at an AFC of 4 or less versus an AFC higher than 4 (c = 0.66) and at FSH levels higher than 13 mIU/mL versus FSH levels of 13 mIU/mL or less (c = 0.67). Sociodemographic and clinical characteristics were compared among women with an AFC of 4 or less versus women with an AFC higher than 4 using t tests, W 2 tests of proportions, and Kaplan-Meier survival analyses.
The difference between year of TVUS examination and year of incident menopause, calculated from age at baseline and self-reported age at natural menopause, was used as the time to incident menopause for survival analysis. Cox proportional hazards regression was performed with AFC (e4 vs 94) as the main exposure variable and with incident natural menopause as outcome. Adjustment for age, current smoking, race, FSH level (913 vs e13 mIU/mL), stable versus unstable menses, hormonal contraceptive use, and CARDIA center was performed. Adjustment for BMI was performed in the subsample with complete data (n = 452). The proportional hazards assumption was tested as the multiplicative interaction of AFC and time to event. Analyses were performed using SAS statistical software, version 9.1 (SAS Institute Inc, Cary, NC). (Table 1) . Women with an AFC of 4 or less (vs women with AFC 94) had a significantly higher incidence of menopause during 7 years of follow-up (hazard ratio [HR], 3.20; 95% CI, 2.11-4.83; Fig. 2 ). Adjustment for age, smoking, race, FSH level (913 vs e13 mIU/mL), stable versus unstable menses, current hormonal contraceptive use, and examination center attenuated the HR, but AFC remained a significant in-dependent predictor of incident natural menopause (HR, 1.89; 95% CI, 1.19-3.02; Table 2 ). Additional adjustment for BMI did not significantly alter the results. In the subsample of women who had stable menses and were not taking hormonal contraception (n = 219), the HR (95% CI) of incident menopause for an AFC of 4 or less versus an AFC higher than 4 was 3.24 (1.51-6.96) after adjustment for age, smoking, race, FSH level (913 vs e13 mIU/mL), and examination center.
RESULTS
In
CONCLUSIONS
Among women initially aged 34 to 49 years, the 7-year hazard of natural menopause is almost twofold higher for women with a low AFC (e4), even after controlling for other known factors associated with menopause. Multiple prospective studies have shown a relationship between a lower AFC and a low production of oocytes during controlled ovarian stimulation for infertility, 16 but an age-independent relationship between AFC and menopause has not been demonstrated previously. One population-based prospective study of AFC and fertility decline is currently ongoing. 17 However, to our knowledge, ours is the first study that is large enough to describe the prospective relationship between AFC and natural menopause.
The markers of ovarian aging included in the 2001 National Institutes of HealthYsponsored Stages of Reproductive Aging Workshop (STRAW) algorithms were menstrual cycle characteristics and FSH levels. 18 Several longitudinal cohort studies of US women, such as the Study of Women Across the Nation 19 and the Michigan Bone Health and Metabolism Study, 20 have followed FSH levels for up to 14 years in initially premenopausal women. These studies have shown that FSH levels increase as women approach menopause. However, FSH level's utility in predicting the timing of a woman's menopause is limited given its variability during the menstrual cycle 21 and its suppression by exogenous estrogen and obesity. 19 The strength of AFC, compared with FSH level, is its stability during the menstrual cycle. However, our study did not measure antimüllerian hormone (AMH) level, which has emerged as a significant biomarker of future menopause in Dutch and Iranian cohorts, 8, 22, 23 with some studies suggesting that it may be a superior marker of menopause compared with AFC. 8 Like AFC, AMH level is stable across the menstrual cycle, although it may be altered by BMI. 24 There is considerable debate regarding the gold standard for defining reproductive failure and ovarian oocyte depletion (ie, menopause). The markers of ovarian aging included in the recently published 2012 National Institutes of HealthYsponsored STRAW +10 algorithms are menstrual cycle characteristics and an expanded repertoire of biomarkers, including FSH level, AFC, and AMH level. 25 The STRAW +10 executive summary states that self-reported menstrual characteristics (ie, a self-report of 12 mo of amenorrhea that hinges on a self-report of a final menstrual period) are the most practical criteria for defining menopause. This consensus definition was partly based on the lack of standardization and cost of biomarker assays. The use of the expanded repertoire of biomarkers included in the STRAW +10 algorithm carried the following caveat: Balthough additional biomarkers, especially AMH and AFC, have considerable promise, the lack of standardized assays and data from noninfertility populations remain important limitations to their incorporation into the STRAW staging system and their utility as clinical tools for staging reproductive aging. [ The strength of our study is that potential biomarkers of menopause were assessed in a community-based noninfertility population. A potential limitation is our definition of natural menopause. Our definition was derived from self-reported questions available in the CARDIA Study at multiple time points (2000-2001, 2005-2006, and 2009-2010) . The definition was thus a practical definition based on the questions regarding menopause that were asked as CARDIA contact points (examinations or telephone surveys). The definition of menopause used was validated by FSH levels (see BValidating the Definition of Menopause[).
Our definition of natural menopause was also validated by one question regarding menstrual periods (data not shown previously). At the 2009-2010 telephone survey, a question regarding menstrual periods was asked of all CARDIA women. Of the 101 women who met the research definition of natural menopause in the current study and who also answered this menstrual period question, 92 (of 98; 94%) women reported that their menstrual periods had stopped completely in the past 12 months or that they had not had a period in more than 12 months. Only 6 of 98 (6%) women gave answers suggesting that they were still having menstrual periods, and it is unknown whether these women were currently taking exogenous hormones that could have caused menstrual bleeding.
We found that AFC was independently associated with incident natural menopause during 7 years of follow-up after accounting for more established markers of the timing of menopause. Although our findings suggest that AFC has the potential to help in predicting the timing of natural menopause, more research is needed to determine whether AFC and other biomarkers of ovarian aging can provide meaningful information for individual women and for the clinicians who care for them. However, from a research and epidemiologic perspective, AFC holds promise as a tool for assessing the relationship between ovarian functional decline and later health outcomes.
